ILLUMINA, INC. (ILMN) research
ILLUMINA, INC.- Sector
- Life Sciences Tools & Services
- Last price
- $273.04
- As of
ILLUMINA, INC. (ILMN): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-17.
As of . Source: SEC EDGAR filings for ILMN. Method and limitations.
Share the ILMN intelligence card
See the full ILMN dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for ILMN on one page. Preview it with sample data, then open it live with a free account.
Preview the ILMN dossierActive signals for ILMN
- highCONSENSUS_SELL
3 tracked funds reduced ILMN this 2026Q2, institutional consensus
- highinsider_cluster_sell
2 insiders at ILMN sold $145.8M this week
- highINSTITUTIONAL_SURGE
Point72 Asset Management, L.P. added +194% to ILMN (2026Q2)
- highINSTITUTIONAL_SURGE
Point72 Asset Management, L.P. added +148% to ILMN (2026Q2)
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 94% of ILMN (2026Q2)
FREE, NO ACCOUNT
Every signal on ILMN, as it fires
You are seeing 5 of 20 signals recorded on ILMN since 2026-05-17.
The five above landed across 3 days. The other 15 were recorded on 4 other days. 11 of the 20 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in ILMN (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 452327109 · 2026Q2 | $145.3M | 0.20% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 452327109 · 2026Q2 | $14.9M | 0.01% | , |
| D. E. Shaw & Co., Inc.CUSIP 452327109 · 2026Q2 | $8.7M | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 452327109 · 2026Q2 | $6.9M | 0.01% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 452327109 · 2026Q2 | $4.1M | 0.00% | , |
| Bridgewater Associates, LPCUSIP 452327109 · 2026Q2 | $2.2M | 0.01% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, ILMN
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
ILMN against its peers
ILMN's operating margin of 18.6% ranks in the 81st percentile of 23 Life Sciences Tools & Services sub-industry peers, fiscal periods ending between 2025-06-30 and 2026-03-31.
| Metric | ILMN | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 4.3B USD | 1.2B USD | 79 | 25 |
| Gross margin | 66.1% | 55.5% | 88 | 11 |
| Operating margin | 18.6% | -3.8% | 81 | 23 |
| Net margin | 19.6% | -3.6% | 90 | 25 |
| Return on equity | 31.2% | -5.0% | 94 | 24 |
| P / E | 50.1x | 39.5x | 63 | 11 |
Peers (25): WAT, IQV, A, MTD, MEDP, TEM, CRL, TXG, TECH, DHR, RGEN, AVTR, BRKR, TMO, SHC, ADPT, ABCL, FTRE, MRVI, DNA, PACB, CTKB, MLAB, OABI, CDXS. Fiscal periods ending between 2025-06-30 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (ILMN: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more ILMN signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to ILMNand get the insider, 13F, options, and confluence read in one view.